Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Neuropathy: early-phase trial registry
11 of 23 indexed Neuropathy trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #724 of 28,707 conditions by registered trial count.
23 US clinical trials · 11 currently recruiting · #724 of 28,707 conditions by registered trial count
Neuropathy: 23 US clinical trials tracked, 11 recruiting.
Neuropathy is the subject of 23 registered US clinical trials on ClinicalTrials.gov, 11 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Dana-Farber Cancer Institute, running 3 of these trials.
Enrollment posture brief
Registry condition neuropathy
OPEN 11 | RECR 48% | LATE 0 | EARLY 3 | RANK #724 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Dementia With Lewy Bodies (48% recruiting · 23 trials)
Neuropathy lists 11 open slots (48% of 23 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Neuropathy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Neuropathy is recruiting above its size-band peers.
11 of 23 indexed trials (47.8%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Neuropathy trials is spread across many organizations.
Dana-Farber Cancer Institute accounts for 3 of 23 trials (13%). 20 distinct sponsors appear on at least one study for this condition label.
-
Typical Neuropathy enrolment sits around 63 participants.
Median target enrolment is 63 among the 23 trials that report a genuine target (sentinel values excluded). 12 of those (52.2%) plan for fewer than 100 participants.
-
Neuropathy splits between interventional and observational designs.
14 interventional and 9 observational studies make up this index (60.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
23 total, page 1 of 1
Establishing Normative Data for Pupillometer Assessments in Neuro-Intensive Care
University of Texas Southwestern Medical Center
NCT02804438
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer
National Cancer Institute (NCI)
NCT02610439
IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy
University of Louisville
NCT04208828
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Jaeb Center for Health Research
NCT06837181
Data Collection of Standard Care of Patients in the EMG Section
National Institute of Neurological Disorders and Stroke (NINDS)
NCT05041387
MRI-Guided Cryoablation to Alleviate Pain in Head, Neck and Spine
Brigham and Women's Hospital
NCT01788410
A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma
Memorial Sloan Kettering Cancer Center
NCT07390617
Clinical Efficacy of the Erchonia EVRL for Providing Temporary Relief of Idiopathic Peripheral Neuropathy Foot Pain
Erchonia Corporation
NCT06912646
Diabetic Neuropathy in Spinal Cord Stimulator Patients
University of Chicago
NCT04687215
Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)
Dana-Farber Cancer Institute
NCT06807294
Daily Hand-Held Vibration Therapy
Indiana University
NCT04207437
Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials
M.D. Anderson Cancer Center
NCT04650178
The Effect of Electroacupuncture on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)
Dana-Farber Cancer Institute
NCT04917796
The Effect of Yoga on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)
Dana-Farber Cancer Institute
NCT05121558
BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma
Bexion Pharmaceuticals
NCT05322590
Improving Autonomic Function and Balance in Diabetic Neuropathy
VA Office of Research and Development
NCT01864460
rTMS in Improving Neuropathy in Patients With Stage I-IV Cancer Who Have Received Oxaliplatin Chemotherapy
M.D. Anderson Cancer Center
NCT03219502
Direct Current Neuromuscular Electrical Stimulation for Treatment of Peripheral Neuropathy
NeuFit - Neurological Fitness and Education
NCT05442021
The Efficacy and Safety of Clonidine Hydrochloride Topical Gel, vs Clonidine Hydrochloride Gel Comparator to Treat Painful Diabetic Neuropathy
BioDelivery Sciences International
NCT02643251
Electro-acupuncture for the Prevention of Taxane Induced Myalgias and Neuropathy
Columbia University
NCT01163682
Tango for Neuropathy Among Breast Cancer Survivors
Ohio State University Comprehensive Cancer Center
NCT05114005
Therapeutic Interventions For Pain Induced By Vincristine Treatment For Childhood Acute Lymphoblastic Leukemia (ALL)
St. Jude Children's Research Hospital
NCT01506453
Diffusion Tensor Imaging in Predicting Development of Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer (CIPN)
University of Arizona
NCT03365895
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Neuropathy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Neuropathy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Neuropathy page
23 registered trials, 11 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 11 Neuropathy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Dana-Farber Cancer Institute sponsors the most Neuropathy trials on record, review their full trial history before evaluating a specific study. See Dana-Farber Cancer Institute's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Neuropathy condition card totals 23 registered trials; most-linked intervention Questionnaire Administration; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.